Skip to content
← Full study record

NCT01308567 · BASELINE

Baseline characteristics

Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer · Source last updated 2019-06-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      391
    2. group Id
      BG001
      value
      389
    3. group Id
      BG002
      value
      388
    4. group Id
      BG003
      value
      1168
    units
    Participants
groups
  1. description
    Docetaxel (TXT) 75 mg/m\^2 IV infusion on Day 1 of each 21-day cycle in combination with Prednisone 10 mg orally, once daily until DP, unacceptable toxicity or participant's refusal.
    id
    BG000
    title
    Docetaxel 75 mg/m^2
  2. description
    Cabazitaxel 20 mg/m\^2 IV infusion on Day 1 of each 21-day cycle in combination with Prednisone 10 mg orally, once daily until DP, unacceptable toxicity or participant's refusal.
    id
    BG001
    title
    Cabazitaxel 20 mg/m^2
  3. description
    Cabazitaxel 25 mg/m\^2 IV infusion on Day 1 of each 21-day cycle in combination with Prednisone 10 mg orally, once daily until DP, unacceptable toxicity or participant's refusal.
    id
    BG002
    title
    Cabazitaxel 25 mg/m^2
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          123
        2. group Id
          BG001
          value
          128
        3. group Id
          BG002
          value
          125
        4. group Id
          BG003
          value
          376
      title
      <65 years
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          181
        2. group Id
          BG001
          value
          187
        3. group Id
          BG002
          value
          182
        4. group Id
          BG003
          value
          550
      title
      65-74 years
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          87
        2. group Id
          BG001
          value
          74
        3. group Id
          BG002
          value
          81
        4. group Id
          BG003
          value
          242
      title
      ≥75 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        4. group Id
          BG003
          value
          0
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          391
        2. group Id
          BG001
          value
          389
        3. group Id
          BG002
          value
          388
        4. group Id
          BG003
          value
          1168
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      391
    2. group Id
      BG001
      value
      389
    3. group Id
      BG002
      value
      388
    4. group Id
      BG003
      value
      1168
    units
    Participants
groups
  1. description
    Docetaxel (TXT) 75 mg/m\^2 IV infusion on Day 1 of each 21-day cycle in combination with Prednisone 10 mg orally, once daily until DP, unacceptable toxicity or participant's refusal.
    id
    BG000
    title
    Docetaxel 75 mg/m^2
  2. description
    Cabazitaxel 20 mg/m\^2 IV infusion on Day 1 of each 21-day cycle in combination with Prednisone 10 mg orally, once daily until DP, unacceptable toxicity or participant's refusal.
    id
    BG001
    title
    Cabazitaxel 20 mg/m^2
  3. description
    Cabazitaxel 25 mg/m\^2 IV infusion on Day 1 of each 21-day cycle in combination with Prednisone 10 mg orally, once daily until DP, unacceptable toxicity or participant's refusal.
    id
    BG002
    title
    Cabazitaxel 25 mg/m^2
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          123
        2. group Id
          BG001
          value
          128
        3. group Id
          BG002
          value
          125
        4. group Id
          BG003
          value
          376
      title
      <65 years
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          181
        2. group Id
          BG001
          value
          187
        3. group Id
          BG002
          value
          182
        4. group Id
          BG003
          value
          550
      title
      65-74 years
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          87
        2. group Id
          BG001
          value
          74
        3. group Id
          BG002
          value
          81
        4. group Id
          BG003
          value
          242
      title
      ≥75 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        4. group Id
          BG003
          value
          0
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          391
        2. group Id
          BG001
          value
          389
        3. group Id
          BG002
          value
          388
        4. group Id
          BG003
          value
          1168
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice